Consistent with this classification, other studies demonstrated that sporadic benign NF2-altered meningiomas showed an immune-rich status characterised by macrophages infiltration, and that some NF2-altered meningiomas have an immune-poor status characterized by clinically malignant outcomes despite being WHO grade I meningioma [31–35]. Here, NF2 is linked to meningioma.